Company / EPS (Diluted)
Verrica Pharmaceuticals Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$14.78
FY2025
5-year range
-$14.78 / -$0.72
FY2021-FY2025
Trend
-898.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -899% YoY in FY2025, a notable deviation from the 4-year average annual change of -234%.
Based on SEC 10-K filings.
-14.78 in FY2025.
Declined from $-0.72 to $-14.78 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 898.6% year-over-year.
- Peak eps (diluted) was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$14.78 | -898.6% |
| FY2024 | -$1.48 | -105.6% |
| FY2023 | -$0.72 | +44.6% |
| FY2022 | -$1.30 | +24.0% |
| FY2021 | -$1.71 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026